BSECompany Update12 Oct 2026 · 12 Oct 2026, 06:34 pm

Dear Sir, Please find Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

Omkar Pharmachem Ltd · 532167

✦ AI Summary

Omkar Pharmachem Ltd has received a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026, confirming the dematerialization of securities and listing on stock exchanges.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

604b127b-86d0-48e9-bb41-a86b259178ce.pdf

pdf

Download →
View document text
39 Owmkar Phavmachem L&D, Date: 12.10.2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub: Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations. 2018 for the Quarter ended on September 30, 2026 Company Scrip Code: 532167 Dear Sir/Madam, We hereby enclose the Confirmation Certificate under regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026 received from Alankit Assignments Limited, Registrar and Share Transfer Agent of the Company. Kindly take the above information on records. Thanking You, Yours faithfully, For Omkar Pharmachem Limited Digtallysignebdy BHAWANI i SGOYAL baeamsiors 1807400530 Bhawani S Goyal Managing Director DIN: 03255804 Add: Ward No-03, Nangal Chaudhry, Narnaul, Mahendragarh, Haryana-123023 Encl: a/a Reg. Off.: 310, Wall Stregt-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163 CIN: L93000G.1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in Health & Weal)t h Clewmkil AssiGNmENTS LiMITED We Manage Both Date: 06/10/2026 Omkar Pharmachem Limited 310 WALL STREET 1. NEAR GUJARAT COLLEGE CROSS ROAD ELLISBRIDGE AHMEDABAD-380006 Subject: Certificate under Regulation 74(5) of the SEBI (Depository and participants) Regulations, 2018 for the quarter ending 30t September 2026. Dear Sir, With reference to the above captioned subject we hereby confirm that the securities received from depository participants for dematerialization during quarter ending 30t September 2026, were confirmed (accepted/ rejected) to the depositories by us and that securities comprised in the said certificates have been listed on stock exchange or exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificate(s) after due verification have been mutilated and cancelled and the name of depository has been substituted in register of member as registered owner within time limit under captioned regulation. We request you to kindly take note of the above. Thanking You, For Alankit Assignments Limited Digitally signed by KAMAL KAMAL GAR g:zfzczm 0.06 12:00:04 +0530' KAMAL GARG (GENERAL MANAGER) SEBI Registiation. Nos INBZORS241, 1M-2406 1288, INELSUB2E0T5, INBLY J84° 260, INFUTOSS1Z32 INCOTOSS 1244, INEZSOES213 5, NEUSLES" Zib, INPLOXN6T3, IN-UF-NSD 1446 IN.UK-CUBL 4381 Registered Office : 20! 8 p [ 110055 Corporate Office : Alankit£ ) rdewalan Extension, New Delh -11005 Phone : +91-11-4254 12 1-2355 2001 | Website : viaw alankitcom 1 e-mail : info@alarkit.com